Literature DB >> 3064093

Transferrin receptor as a potential therapeutic target.

I S Trowbridge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3064093     DOI： 10.1159/000416377

Source DB:  PubMed          Journal:  Prog Allergy        ISSN： 0079-6034


× No keyword cloud information.
  8 in total

1.  An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells.

Authors:  Patrick P Ng; Jay S Dela Cruz; David N Sorour; James M Stinebaugh; Seung-Uon Shin; Daniel S Shin; Sherie L Morrison; Manuel L Penichet
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

2.  Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor.

Authors:  Patrick P Ng; Gustavo Helguera; Tracy R Daniels; Simon Z Lomas; Jose A Rodriguez; Gary Schiller; Benjamin Bonavida; Sherie L Morrison; Manuel L Penichet
Journal:  Blood       Date:  2006-06-27       Impact factor: 22.113

3.  Antigen forks: bispecific reagents that inhibit cell growth by binding selected pairs of tumor antigens.

Authors:  D B Ring; S T Hsieh-Ma; T Shi; J Reeder
Journal:  Cancer Immunol Immunother       Date:  1994-07       Impact factor: 6.968

4.  Brain tumor iron uptake measured with positron emission tomography and 52Fe-citrate.

Authors:  U Roelcke; K L Leenders; K von Ammon; E W Radü; P Vontobel; I Günther; M Psylla
Journal:  J Neurooncol       Date:  1996-08       Impact factor: 4.130

5.  Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAb.

Authors:  M Caraglia; P Tagliaferri; P Correale; G Genua; A Pinto; S Del Vecchio; G Esposito; A R Bianco
Journal:  Cancer Immunol Immunother       Date:  1993-08       Impact factor: 6.968

6.  A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells.

Authors:  Megumi Kawamoto; Tomohisa Horibe; Masayuki Kohno; Koji Kawakami
Journal:  BMC Cancer       Date:  2011-08-18       Impact factor: 4.430

7.  Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study.

Authors:  Mehdi Farokhnia; Gray R McDiarmid; Matthew N Newmeyer; Vikas Munjal; Osama A Abulseoud; Marilyn A Huestis; Lorenzo Leggio
Journal:  Transl Psychiatry       Date:  2020-02-19       Impact factor: 6.222

Review 8.  IgG Fusion Proteins for Brain Delivery of Biologics via Blood-Brain Barrier Receptor-Mediated Transport.

Authors:  Ruben J Boado
Journal:  Pharmaceutics       Date:  2022-07-15       Impact factor: 6.525
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.